233 related articles for article (PubMed ID: 35008647)
41. Beta cyclodextrins bind, stabilize, and remove lipofuscin bisretinoids from retinal pigment epithelium.
Nociari MM; Lehmann GL; Perez Bay AE; Radu RA; Jiang Z; Goicochea S; Schreiner R; Warren JD; Shan J; Adam de Beaumais S; Ménand M; Sollogoub M; Maxfield FR; Rodriguez-Boulan E
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):E1402-8. PubMed ID: 24706818
[TBL] [Abstract][Full Text] [Related]
42. Protein-Mediated Carotenoid Delivery Suppresses the Photoinducible Oxidation of Lipofuscin in Retinal Pigment Epithelial Cells.
Semenov AN; Maksimov EG; Moysenovich AM; Yakovleva MA; Tsoraev GV; Ramonova AA; Shirshin EA; Sluchanko NN; Feldman TB; Rubin AB; Kirpichnikov MP; Ostrovsky MA
Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36829973
[TBL] [Abstract][Full Text] [Related]
43. Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment.
Petrukhin K
Drug Discov Today Ther Strateg; 2013; 10(1):e11-e20. PubMed ID: 25152755
[TBL] [Abstract][Full Text] [Related]
44. Identification of a novel lipofuscin pigment (iisoA2E) in retina and its effects in the retinal pigment epithelial cells.
Li J; Yao K; Yu X; Dong X; Gan L; Luo C; Wu Y
J Biol Chem; 2013 Dec; 288(50):35671-82. PubMed ID: 24169698
[TBL] [Abstract][Full Text] [Related]
45. Oxidation of A2E results in the formation of highly reactive aldehydes and ketones.
Wang Z; Keller LM; Dillon J; Gaillard ER
Photochem Photobiol; 2006; 82(5):1251-7. PubMed ID: 16813456
[TBL] [Abstract][Full Text] [Related]
46. Light damage in Abca4 and Rpe65rd12 mice.
Wu L; Ueda K; Nagasaki T; Sparrow JR
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1910-8. PubMed ID: 24576873
[TBL] [Abstract][Full Text] [Related]
47. Fundus autofluorescence in the Abca4(-/-) mouse model of Stargardt disease--correlation with accumulation of A2E, retinal function, and histology.
Charbel Issa P; Barnard AR; Singh MS; Carter E; Jiang Z; Radu RA; Schraermeyer U; MacLaren RE
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5602-12. PubMed ID: 23761084
[TBL] [Abstract][Full Text] [Related]
48. Fundus autofluorescence and the bisretinoids of retina.
Sparrow JR; Wu Y; Nagasaki T; Yoon KD; Yamamoto K; Zhou J
Photochem Photobiol Sci; 2010 Nov; 9(11):1480-9. PubMed ID: 20862444
[TBL] [Abstract][Full Text] [Related]
49. Increased cone sensitivity to ABCA4 deficiency provides insight into macular vision loss in Stargardt's dystrophy.
Conley SM; Cai X; Makkia R; Wu Y; Sparrow JR; Naash MI
Biochim Biophys Acta; 2012 Jul; 1822(7):1169-79. PubMed ID: 22033104
[TBL] [Abstract][Full Text] [Related]
50. Characterization of dihydro-A2PE: an intermediate in the A2E biosynthetic pathway.
Kim SR; He J; Yanase E; Jang YP; Berova N; Sparrow JR; Nakanishi K
Biochemistry; 2007 Sep; 46(35):10122-9. PubMed ID: 17685561
[TBL] [Abstract][Full Text] [Related]
51. The 5HT1a receptor agonist 8-Oh DPAT induces protection from lipofuscin accumulation and oxidative stress in the retinal pigment epithelium.
Thampi P; Rao HV; Mitter SK; Cai J; Mao H; Li H; Seo S; Qi X; Lewin AS; Romano C; Boulton ME
PLoS One; 2012; 7(4):e34468. PubMed ID: 22509307
[TBL] [Abstract][Full Text] [Related]
52. Light-induced release of A2E photooxidation toxic products from lipofuscin granules of human retinal pigment epithelium.
Dontsov AE; Sakina NL; Golubkov AM; Ostrovsky MA
Dokl Biochem Biophys; 2009; 425():98-101. PubMed ID: 19496332
[No Abstract] [Full Text] [Related]
53. A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle.
Racz B; Varadi A; Kong J; Allikmets R; Pearson PG; Johnson G; Cioffi CL; Petrukhin K
J Biol Chem; 2018 Jul; 293(29):11574-11588. PubMed ID: 29871924
[TBL] [Abstract][Full Text] [Related]
54. Photooxidation of RPE lipofuscin bisretinoids enhances fluorescence intensity.
Kim SR; Jang YP; Sparrow JR
Vision Res; 2010 Mar; 50(7):729-36. PubMed ID: 19800359
[TBL] [Abstract][Full Text] [Related]
55. Lipofuscin and macular degeneration.
Wolf G
Nutr Rev; 2003 Oct; 61(10):342-6. PubMed ID: 14604266
[TBL] [Abstract][Full Text] [Related]
56. Retinal pigment epithelium lipofuscin proteomics.
Ng KP; Gugiu B; Renganathan K; Davies MW; Gu X; Crabb JS; Kim SR; Rózanowska MB; Bonilha VL; Rayborn ME; Salomon RG; Sparrow JR; Boulton ME; Hollyfield JG; Crabb JW
Mol Cell Proteomics; 2008 Jul; 7(7):1397-405. PubMed ID: 18436525
[TBL] [Abstract][Full Text] [Related]
57. Oxidative stress, polyunsaturated fatty acids-derived oxidation products and bisretinoids as potential inducers of CNS diseases: focus on age-related macular degeneration.
Nowak JZ
Pharmacol Rep; 2013; 65(2):288-304. PubMed ID: 23744414
[TBL] [Abstract][Full Text] [Related]
58. Lipofuscin and A2E accumulate with age in the retinal pigment epithelium of Nrl-/- mice.
Boyer NP; Tang PH; Higbee D; Ablonczy Z; Crouch RK; Koutalos Y
Photochem Photobiol; 2012; 88(6):1373-7. PubMed ID: 22417141
[TBL] [Abstract][Full Text] [Related]
59. Iron-induced accumulation of lipofuscin-like fluorescent pigment in the retinal pigment epithelium.
Katz ML; Stientjes HJ; Gao CL; Christianson JS
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3161-71. PubMed ID: 8407225
[TBL] [Abstract][Full Text] [Related]
60. Spectral profiling of autofluorescence associated with lipofuscin, Bruch's Membrane, and sub-RPE deposits in normal and AMD eyes.
Marmorstein AD; Marmorstein LY; Sakaguchi H; Hollyfield JG
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2435-41. PubMed ID: 12091448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
